First Quarter Results

Cannabis Vape Co. Ispire Grows Abroad As US Sales Decline Slows Q1 Revenue

PharmaCielo Cannabis Co. Narrows Net Loss By 31% YoY In Q1, CEO Says Cost Reduction Efforts Showing Results

Marijuana Fintech Co. POSaBIT Reports 67% YoY Drop In Q1 Revenue, Renews Focus On Sustainable Profitability And Growth

PharmaCielo Cannabis Co. Narrows Net Loss By 31% YoY In Q1, CEO Says Cost Reduction Efforts Showing Results

Marijuana Fintech Co. POSaBIT Reports 67% YoY Drop In Q1 Revenue, Renews Focus On Sustainable Profitability And Growth

Grown Rogue Reports Record Q1 Revenue, CEO Calls These Two States 'Primary Growth Drivers'

Decibel Cannabis Reports 16% YoY Drop In Q1 Revenue, CEO Expects Improved Q2 And 'Continued Path To Sustainable Growth And Profitability'

Grown Rogue Reports Record Q1 Revenue, CEO Calls These Two States 'Primary Growth Drivers'

Decibel Cannabis Reports 16% YoY Drop In Q1 Revenue, CEO Expects Improved Q2 And 'Continued Path To Sustainable Growth And Profitability'

Cannabis Company 4Front Reports 28% YoY Drop In Q1 Revenue While Net Loss Grows, CEO Optimistic With Biden's Marijuana Rescheduling News

Medical Marijuana Giant Trulieve, Backer Of Florida's Recreational Cannabis Ballot, Narrows Loss, Reports Uptick In Q1 Revenue, Gross Profit

First Quarter Results Recent News

Pervasip Reports Slight YoY Decrease In Q1 Revenue As It Prepares For Cannabis Spin-Off

Pervasip announced on Tuesday its 2024 first-quarter financial results. Simultaneously, the Seattle, Washington-based company said it's still in the restructuring process and preparation for the spin-out of all of its cannabis assets. "We are entering our final phase of restructuring which involves making difficult decisions to ensure additional expense reductions and separating the company from assets it has held for many years," German Burtscher, Pervasip's president and chief executive officer, said. Additionally, as part of the restructuring, George Jordan has resigned from his duties as CFO and COO of the company and will stay on as an advisor, supporting management through its final phase of changes in preparation for the spin-out of Artizen Corporation.

Organigram Reports 16% YoY Revenue Drop But Kicks Off Year 'With A Bang,' Says CEO On Hundreds Of Millions In Tobacco Giant BAT Investment

Canadian cannabis producer Organigram reported a 16% decrease in net revenue for Q1 2024 due to a reduction in international revenue and medical sales. The company announced in November that it had received a CA$124.6m ($93m) strategic equity investment from BT DE Investments, a subsidiary of tobacco company British American Tobacco. Organigram shareholders approved the investment in January, and the company completed the first tranche of the investment for $41.5m. CEO Beena Goldenberg said the investment had removed a significant amount of risk from Organigram's business and enhanced its competitive advantages. The investment allows the cannabis producer to utilize its facilities, research and development capabilities, and market leadership to expand its reach within the Canadian market and beyond. Organigram's Q1 financial highlights included a drop in gross margin, an increase in selling and administrative expenses, a net loss of CA$15.8m, and positive adjusted EBITDA of CA$135,000.

Scotts Miracle-Gro's Cannabis-Focused Subsidiary Reports 39% YoY Revenue Drop In Q1

The Scotts Miracle-Gro Company has reported financial results for Q1 2024, with sales dropping 22% to $410.4m compared to $526.6m the previous year. Net sales for its US consumer division fell 17% to $306.7m, while subsidiary the Hawthorne Gardening Company saw sales decline 39% from $131.5m to $80.1m. The firm's GAAP and non-GAAP adjusted gross margin rates stood at 15.2% and 13.7%, respectively, compared to 18.2% and 20.1% the previous year. The company's CEO and chairman, Jim Hagedorn, reaffirmed its guidance for high-single-digit growth in its consumer business. Meanwhile, for Hawthorne, the firm said it was taking "actions to ensure the business remains cash flow positive in fiscal 2024 and a major contributor to our debt paydown".

Pot Products Drive Profit For This Vape-Tech Company: Q3 Revenue Spikes YoY, Loss Narrows

Ispire Technology Inc. (NASDAQ: ISPR) reported its first quarter financial results on Tuesday, revealing a 59.1% year-over-year increase in revenue to $42.9 million in the three months ended Sept. 30, 2023.

Analyst Touts 'Key Underlying Improvements' For HEXO Despite Q1 Revenue Drop

Hexo Corp. (NASDAQ: HEXO) reported a 29% year-over-year and 16% sequential decrease in net revenue to CA$ 35.8 million ($26.3 million) in the first quarter of fiscal 2023.

ScottsMiracle-Gro Posts Q1 Profit, Hawthorne Gardening Revenue Spikes 71% To $309M

The Scotts Miracle-Gro Company (NYSE: SMG) reported Wednesday a 105% sales spike, reaching $748.6 million in the first three months of this fiscal year.

Aphria Revenue Spikes 23% In Yet Another Growth Quarter

Aphria Inc. (TSX: APHA) (NASDAQ: APHA) has achieved record gross revenue of CA$69.6 million in the first quarter, up by 23% compared to the previous period. This is the Leamington, Ontario-based company's sixth consecutive quarter of growth.

Radient Posts $5.5M Net Loss, Continues To Restructure Operations

Radient Technologies Inc. (OTCQX: RDDTF) revealed Thursday it generated $42,435 in revenues f

Quarterly Earnings: Sproutly Transforms Business, TopStrike's Revenue Declines

Sproutly Accelerates 'Business Transformation Plan' In Q1

J.B. Hunt Misses Analysts' First Quarter Earnings And Revenue Estimates

Investors Pop SodaStream's Q1 Bubble, But Shares Rebound

Charges From Fiat Merger Hamper Chrysler's Q1 Results

Investors Moo: Shares Of Deans Foods Tank As Management Blames High Milk Prices For Weak Q1

TripAdvisor Shares Ride After-Hour Roller Coaster Following 1Q14 Results

Gamers Rejoice: Activision Shares Jump Following Earnings & Guidance